Search

Your search keyword '"Oude Elberink, J Hanneke N G"' showing total 9 results
Start Over Author "Oude Elberink, J Hanneke N G"
9 results on '"Oude Elberink, J Hanneke N G"'

1. Erratum to : Allergen immunotherapy for allergic rhinoconjunctivitis: Protocol for a systematic review (Clinical and Translational Allergy (2016) 6 (12) DOI: 10.1186/s13601-016-0099-6)

Author

Dhami, Sangeeta, Nurmatov, Ulugbek, Roberts, Graham, Pfaar, Oliver, Muraro, Antonella, Ansotegui, Ignacio J, Calderon, Moises, Cingi, Cemal, Demoly, Pascal, Durham, Stephen, van Wijk, Ronald Gerth, Halken, Susanne, Hamelmann, Eckard, Hellings, Peter W, Jacobsen, Lars, Knol, Edward, Linnemann, Desiree Larenas, Lin, Sandra, Maggina, Vivian, Oude Elberink, J Hanneke N G, Pajno, Giovanni Battista, Panwankar, Ruby, Pastorello, Elideanna, Pitsios, Constantinos, Rotiroti, Giuseppina, Timmermans, Frans, Tsilochristou, Olympia, Varga, Eva-Maria, Wilkinson, Jamie, Williams, Andrew, Worm, Margitta, Zhang, Luo, and Sheikh, Aziz

Subjects
Published Erratum, Immunology and Allergy
Abstract

Unfortunately this article [1] was published with an error in the Funding section. The BM4SIT project is not acknowledged. This section should be corrected to the below: Funding EAACI and the BM4SIT project (Grant Number 601763) in the European Union's Seventh Framework Programme FP7.

Published
2017

2. Allergen immunotherapy for allergic rhinoconjunctivitis : A systematic overview of systematic reviews

Author

Nurmatov, Ulugbek, Dhami, Sangeeta, Arasi, Stefania, Roberts, Graham, Pfaar, Oliver, Muraro, Antonella, Ansotegui, Ignacio J, Calderon, Moises, Cingi, Cemal, Durham, Stephen, van Wijk, Roy Gerth, Halken, Susanne, Hamelmann, Eckard, Hellings, Peter W, Jacobsen, Lars, Knol, Edward, Larenas-Linnemann, Desiree, Lin, Sandra Y, Maggina, Vivian, Oude Elberink, J Hanneke N G, Pajno, Giovanni Battista, Panwankar, Ruby, Pastorello, Elideanna, Pitsios, Constantinos, Rotiroti, Giuseppina, Timmermans, Frans, Tsilochristou, Olympia, Varga, Eva-Maria, Wilkinson, Jamie, Williams, Andrew, Worm, Margitta, Zhang, Luo, Sheikh, Aziz, Nurmatov, Ulugbek, Dhami, Sangeeta, Arasi, Stefania, Roberts, Graham, Pfaar, Oliver, Muraro, Antonella, Ansotegui, Ignacio J, Calderon, Moises, Cingi, Cemal, Durham, Stephen, van Wijk, Roy Gerth, Halken, Susanne, Hamelmann, Eckard, Hellings, Peter W, Jacobsen, Lars, Knol, Edward, Larenas-Linnemann, Desiree, Lin, Sandra Y, Maggina, Vivian, Oude Elberink, J Hanneke N G, Pajno, Giovanni Battista, Panwankar, Ruby, Pastorello, Elideanna, Pitsios, Constantinos, Rotiroti, Giuseppina, Timmermans, Frans, Tsilochristou, Olympia, Varga, Eva-Maria, Wilkinson, Jamie, Williams, Andrew, Worm, Margitta, Zhang, Luo, and Sheikh, Aziz

Published
2017

3. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic overview of systematic reviews

Author

CTI, MS Dermatologie/Allergologie, Infection & Immunity, Nurmatov, Ulugbek, Dhami, Sangeeta, Arasi, Stefania, Roberts, Graham, Pfaar, Oliver, Muraro, Antonella, Ansotegui, Ignacio J, Calderon, Moises, Cingi, Cemal, Durham, Stephen, van Wijk, Roy Gerth, Halken, Susanne, Hamelmann, Eckard, Hellings, Peter W, Jacobsen, Lars, Knol, Edward, Larenas-Linnemann, Desiree, Lin, Sandra Y, Maggina, Vivian, Oude Elberink, J Hanneke N G, Pajno, Giovanni Battista, Panwankar, Ruby, Pastorello, Elideanna, Pitsios, Constantinos, Rotiroti, Giuseppina, Timmermans, Frans, Tsilochristou, Olympia, Varga, Eva-Maria, Wilkinson, Jamie, Williams, Andrew, Worm, Margitta, Zhang, Luo, Sheikh, Aziz, CTI, MS Dermatologie/Allergologie, Infection & Immunity, Nurmatov, Ulugbek, Dhami, Sangeeta, Arasi, Stefania, Roberts, Graham, Pfaar, Oliver, Muraro, Antonella, Ansotegui, Ignacio J, Calderon, Moises, Cingi, Cemal, Durham, Stephen, van Wijk, Roy Gerth, Halken, Susanne, Hamelmann, Eckard, Hellings, Peter W, Jacobsen, Lars, Knol, Edward, Larenas-Linnemann, Desiree, Lin, Sandra Y, Maggina, Vivian, Oude Elberink, J Hanneke N G, Pajno, Giovanni Battista, Panwankar, Ruby, Pastorello, Elideanna, Pitsios, Constantinos, Rotiroti, Giuseppina, Timmermans, Frans, Tsilochristou, Olympia, Varga, Eva-Maria, Wilkinson, Jamie, Williams, Andrew, Worm, Margitta, Zhang, Luo, and Sheikh, Aziz

Published
2017

4. Erratum to: Allergen immunotherapy for allergic rhinoconjunctivitis: Protocol for a systematic review (Clinical and Translational Allergy (2016) 6 (12) DOI: 10.1186/s13601-016-0099-6)

Author

MS Dermatologie/Allergologie, CDL Celdiagnostiek, Infection & Immunity, CTI, Dhami, Sangeeta, Nurmatov, Ulugbek, Roberts, Graham, Pfaar, Oliver, Muraro, Antonella, Ansotegui, Ignacio J, Calderon, Moises, Cingi, Cemal, Demoly, Pascal, Durham, Stephen, van Wijk, Ronald Gerth, Halken, Susanne, Hamelmann, Eckard, Hellings, Peter W, Jacobsen, Lars, Knol, Edward, Linnemann, Desiree Larenas, Lin, Sandra, Maggina, Vivian, Oude Elberink, J Hanneke N G, Pajno, Giovanni Battista, Panwankar, Ruby, Pastorello, Elideanna, Pitsios, Constantinos, Rotiroti, Giuseppina, Timmermans, Frans, Tsilochristou, Olympia, Varga, Eva-Maria, Wilkinson, Jamie, Williams, Andrew, Worm, Margitta, Zhang, Luo, Sheikh, Aziz, MS Dermatologie/Allergologie, CDL Celdiagnostiek, Infection & Immunity, CTI, Dhami, Sangeeta, Nurmatov, Ulugbek, Roberts, Graham, Pfaar, Oliver, Muraro, Antonella, Ansotegui, Ignacio J, Calderon, Moises, Cingi, Cemal, Demoly, Pascal, Durham, Stephen, van Wijk, Ronald Gerth, Halken, Susanne, Hamelmann, Eckard, Hellings, Peter W, Jacobsen, Lars, Knol, Edward, Linnemann, Desiree Larenas, Lin, Sandra, Maggina, Vivian, Oude Elberink, J Hanneke N G, Pajno, Giovanni Battista, Panwankar, Ruby, Pastorello, Elideanna, Pitsios, Constantinos, Rotiroti, Giuseppina, Timmermans, Frans, Tsilochristou, Olympia, Varga, Eva-Maria, Wilkinson, Jamie, Williams, Andrew, Worm, Margitta, Zhang, Luo, and Sheikh, Aziz

Published
2017

5. Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions : Lesion Clearance Is Related to the Strength of the T-Cell Response

Author

van Poelgeest, Mariëtte I E, Welters, Marij J P, Vermeij, Renee, Stynenbosch, Linda F M, Loof, Nikki M, Berends-van der Meer, Dorien M A, Löwik, Margriet J G, Hamming, Ineke L E, van Esch, Edith M G, Hellebrekers, Bart W J, van Beurden, Marc, Schreuder, Henk W, Kagie, Marjolein J, Trimbos, J Baptist M Z, Fathers, Lorraine M, Daemen, Toos, Hollema, Harry, Valentijn, A Rob P M, Oostendorp, Jaap, Oude Elberink, J Hanneke N G, Fleuren, Gertjan J, Bosse, Tjalling, Kenter, Gemma G, Stijnen, Theo, Nijman, Hans W, Melief, Cornelis J M, van der Burg, Sjoerd H, van Poelgeest, Mariëtte I E, Welters, Marij J P, Vermeij, Renee, Stynenbosch, Linda F M, Loof, Nikki M, Berends-van der Meer, Dorien M A, Löwik, Margriet J G, Hamming, Ineke L E, van Esch, Edith M G, Hellebrekers, Bart W J, van Beurden, Marc, Schreuder, Henk W, Kagie, Marjolein J, Trimbos, J Baptist M Z, Fathers, Lorraine M, Daemen, Toos, Hollema, Harry, Valentijn, A Rob P M, Oostendorp, Jaap, Oude Elberink, J Hanneke N G, Fleuren, Gertjan J, Bosse, Tjalling, Kenter, Gemma G, Stijnen, Theo, Nijman, Hans W, Melief, Cornelis J M, and van der Burg, Sjoerd H

Published
2016

6. Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

Author

MS Gynaecologische Oncologie, Cancer, van Poelgeest, Mariëtte I E, Welters, Marij J P, Vermeij, Renee, Stynenbosch, Linda F M, Loof, Nikki M, Berends-van der Meer, Dorien M A, Löwik, Margriet J G, Hamming, Ineke L E, van Esch, Edith M G, Hellebrekers, Bart W J, van Beurden, Marc, Schreuder, Henk W, Kagie, Marjolein J, Trimbos, J Baptist M Z, Fathers, Lorraine M, Daemen, Toos, Hollema, Harry, Valentijn, A Rob P M, Oostendorp, Jaap, Oude Elberink, J Hanneke N G, Fleuren, Gertjan J, Bosse, Tjalling, Kenter, Gemma G, Stijnen, Theo, Nijman, Hans W, Melief, Cornelis J M, van der Burg, Sjoerd H, MS Gynaecologische Oncologie, Cancer, van Poelgeest, Mariëtte I E, Welters, Marij J P, Vermeij, Renee, Stynenbosch, Linda F M, Loof, Nikki M, Berends-van der Meer, Dorien M A, Löwik, Margriet J G, Hamming, Ineke L E, van Esch, Edith M G, Hellebrekers, Bart W J, van Beurden, Marc, Schreuder, Henk W, Kagie, Marjolein J, Trimbos, J Baptist M Z, Fathers, Lorraine M, Daemen, Toos, Hollema, Harry, Valentijn, A Rob P M, Oostendorp, Jaap, Oude Elberink, J Hanneke N G, Fleuren, Gertjan J, Bosse, Tjalling, Kenter, Gemma G, Stijnen, Theo, Nijman, Hans W, Melief, Cornelis J M, and van der Burg, Sjoerd H

Published
2016

7. [Idiopathic mast cell activation syndrome].

Author

van Daele PLA, Hermans MAW, Oude Elberink JHNG, and van Wijk RG

Subjects
Humans, Male, Mast Cells, Mast Cell Activation Syndrome, Mastocytosis diagnosis, Mastocytosis therapy
Abstract

Background: Idiopathic mast cell activation syndrome (MCAS) is one of the causes for recurrent complaints. The diagnosis is sometimes delayed but also often made incorrectly., Case: Our patient presented with recurrent attacks of itching, redness of the skin, diarrhea and near collapse. During an attack his serum tryptase level rose significantly. We could not identify an underlying trigger. A diagnosis of idiopathic mast cell activation syndrome was made. He was successfully treated with a combination of H1 and H2 blockade., Conclusion: MCAS is characterized by recurrent complaints. To make the diagnosis a significant rise in mast cell mediators is required. Given the diversity of symptoms many patients with somatically unexplained symptoms wrongfully believe to be suffering from MCAS.

Published
2022

8. Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response.

Author

van Poelgeest MI, Welters MJ, Vermeij R, Stynenbosch LF, Loof NM, Berends-van der Meer DM, Löwik MJ, Hamming IL, van Esch EM, Hellebrekers BW, van Beurden M, Schreuder HW, Kagie MJ, Trimbos JB, Fathers LM, Daemen T, Hollema H, Valentijn AR, Oostendorp J, Oude Elberink JH, Fleuren GJ, Bosse T, Kenter GG, Stijnen T, Nijman HW, Melief CJ, and van der Burg SH

Subjects
Adult, Aged, Aminoquinolines therapeutic use, CD8-Positive T-Lymphocytes virology, Cancer Vaccines immunology, Carcinoma in Situ drug therapy, Carcinoma in Situ immunology, Female, Human papillomavirus 16 drug effects, Humans, Imiquimod, Interferon-gamma immunology, Middle Aged, Papillomavirus E7 Proteins immunology, Papillomavirus Infections virology, Uterine Cervical Neoplasms drug therapy, Uterine Cervical Neoplasms immunology, Vaccination methods, Vaginal Neoplasms virology, Vulvar Neoplasms virology, Young Adult, CD8-Positive T-Lymphocytes immunology, Human papillomavirus 16 immunology, Oncogene Proteins, Viral immunology, Papillomavirus Infections immunology, Papillomavirus Vaccines immunology, Vaginal Neoplasms immunology, Vulvar Neoplasms immunology
Abstract

Purpose: Therapeutic vaccination with human papillomavirus type 16 (HPV16) E6 and E7 synthetic long peptides (SLP) is effective against HPV16-induced high-grade vulvar and vaginal intraepithelial neoplasia (VIN/VaIN). However, clinical nonresponders displayed weak CD8(+) T-cell reactivity. Here, we studied if imiquimod applied at the vaccine site could improve CD8(+) T-cell reactivity, clinical efficacy, and safety of HPV16-SLP (ISA101)., Experimental Design: A multicenter open-label, randomized controlled trial was conducted in patients with HPV16(+) high-grade VIN/VaIN. Patients received ISA101 vaccination with or without application of 5% imiquimod at the vaccine site. The primary objective was the induction of a directly ex vivo detectable HPV16-specific CD8(+) T-cell response. The secondary objectives were clinical responses (lesion size, histology, and virology) and their relation with the strength of vaccination-induced immune responses., Results: Forty-three patients were assigned to either ISA101 with imiquimod (n = 21) or ISA101 only (n = 22). Imiquimod did not improve the outcomes of vaccination. However, vaccine-induced clinical responses were observed in 18 of 34 (53%; 95% CI, 35.1-70.2) patients at 3 months and in 15 of 29 (52%; 95% CI, 32.5-70.6) patients, 8 of whom displayed a complete histologic response, at 12 months after the last vaccination. All patients displayed vaccine-induced T-cell responses, which were significantly stronger in patients with complete responses. Importantly, viral clearance occurred in all but one of the patients with complete histologic clearance., Conclusions: This new study confirms that clinical efficacy of ISA101 vaccination is related to the strength of vaccine-induced HPV16-specific T-cell immunity and is an effective therapy for HPV16-induced high-grade VIN/VaIN. Clin Cancer Res; 22(10); 2342-50. ©2016 AACRSee related commentary by Karaki et al., p. 2317., (©2016 American Association for Cancer Research.)

Published
2016
Full Text
View/download PDF

9. [Allergy while fishing].

Author

Tideman SW and Oude Elberink JH

Subjects
Adult, Animals, Fishes, Humans, Larva immunology, Male, Recreation, Skin Tests, Conjunctivitis, Allergic diagnosis, Conjunctivitis, Allergic immunology, Diptera immunology
Abstract

Two 37- and 39-year-old men without any relevant medical history developed allergic rhinoconjunctivitis while fishing. In the differential diagnosis allergy to pollen or fish feed ingredients, or fish or maggot contact allergy were considered. Further investigation of the case histories found that both men had been in direct contact with maggots of the Calliphora vomitoria fly. The allergic reaction attributed to the maggot exposure was confirmed by a prick-to-prick test with the maggots in both cases. The limited literature available on this subject supports the diagnosis.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results